Theranostics
2018; 8(14):3870-3871.
doi:10.7150/thno.27810 This issueCite
Editorial
Oxygenating the way for enhanced chemophototherapy
Wen Jiang1, Ian Michael Delahunty1, Jin Xie1,2 ✉
1. Department of Chemistry, University of Georgia, Athens, GA 30602, USA 2. Bio-Imaging Research Center, University of Georgia, Athens, GA 30602, USA
✉ Corresponding author: jinxie@uga.edu
Citation:
Jiang W, Delahunty IM, Xie J. Oxygenating the way for enhanced chemophototherapy. Theranostics 2018; 8(14):3870-3871. doi:10.7150/thno.27810. https://www.thno.org/v08p3870.htm
Hypoxia is behind tumor resistance in both chemotherapy and photodynamic therapy. This editorial highlights a study by Cai et al. [12] that a hemoglobin and human serum albumin hybrid protein nanoparticle can simultaneously deliver O2, chemotherapeutics, and photosensitizers to tumors for enhanced chemophototherapy.
Jiang, W., Delahunty, I.M., Xie, J. (2018). Oxygenating the way for enhanced chemophototherapy. Theranostics, 8(14), 3870-3871. https://doi.org/10.7150/thno.27810.
ACS
Jiang, W.; Delahunty, I.M.; Xie, J. Oxygenating the way for enhanced chemophototherapy. Theranostics 2018, 8 (14), 3870-3871. DOI: 10.7150/thno.27810.
NLM
Jiang W, Delahunty IM, Xie J. Oxygenating the way for enhanced chemophototherapy. Theranostics 2018; 8(14):3870-3871. doi:10.7150/thno.27810. https://www.thno.org/v08p3870.htm
CSE
Jiang W, Delahunty IM, Xie J. 2018. Oxygenating the way for enhanced chemophototherapy. Theranostics. 8(14):3870-3871.
This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.